Posttranslational deamidation of proteins: The case of hemoglobin J Sardegna [α50 (CD8)His→Asn→Asp]

Clinical Chemistry

Volumn 45, Issue 1, 1999, Pages 21-28

  Paleari, Renata ^a   Paglietti, Elisabetta ^b   Mosca, Andrea ^a,c   Mortarino, Michele ^a   Maccioni, Liliana ^b   Satta, Stefania ^b   Cao, Antonio ^b   Galanello, Renzo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c LITA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN J;

AMINO ACID SUBSTITUTION; ARTICLE; DEAMINATION; DNA DETERMINATION; DNA SEQUENCE; HEMOGLOBINOPATHY; HUMAN; ISOELECTRIC FOCUSING; PROTEIN ANALYSIS; PROTEIN PROCESSING;

ASPARAGINE; ASPARTIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; ELECTROPHORESIS, CELLULOSE ACETATE; HEMOGLOBIN J; HISTIDINE; HUMANS; ISOELECTRIC FOCUSING; POINT MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE ANALYSIS, DNA;

EID: 0032899756     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 1. Tangheroni W, Zorcolo G, Gallo E, Lehmann H. Haemoglobin J Sardegna: α50(CD8)Histidine→Aspartic Acid. Nature 1968;218: 470-1.
2. 2. Masala B. Hemoglobinopathies in Sardegna. Hemoglobin 1992; 16:331-51.
3. 3. Manca L, Masala B. Identification of Hb J-Sardegna [α50(CE8)His→Asp] by HPLC and its incidence in northern Sardinia. Hemoglobin 1989;13:33-44.
4. 4. Gallo E, Pugliatti L, Ricco G, Pich PG, Pinna G, Mazza U. A case of haemoglobin J Sardegna-α-thalassemia double heterozygosis. Acta Haematol 1972;47:311-20.
5. 5. Meloni T, Pilo G, Camardella L, Concedda F, Lania A, Pepe G, Luzzato L. Coexistence of three hemoglobins with different α-chains in two unrelated children (with family studies indicating polymorphism in the number of α-globin genes in the Sardinian population). Blood 1980;55:1025-32.
6. 6. Maccioni L, Galanello R, Melis MA, Cao A. Hemoglobin constitution of double heterozygotes for α or β-thalassemia and Hb J Sardegna. Hemoglobin 1984;8:497-507.
7. 7. Dode C, Krishnamoorthy R, Lamb J, Rochette J. Rapid analysis of -alpha 3.7 thalassaemia and alpha alpha alpha anti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 1993;83: 105-11.
8. 8. Bowden DK, Vickers MA, Higgs DR. A PCR-based strategy to detect the common severe determinants of alpha thalassaemia. Br J Haematol 1992;81:104-8.
9. 9. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain termination inhibitors. Proc Natl Acad Sci U S A 1977;74:5463-7.
10. 10. Chomeczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
11. 11. US Department of Health and Human Services, Public Health Service. Laboratory methods for detecting hemoglobinopathies. Atlanta, GA: Centers for Disease Control, 1984:45-58.
12. 12. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In: Tietz NW, ed. Fundamentals of clinical chemistry, 3rd ed. Philadelphia, PA: WB Sauders, 1987:803-6.
13. 13. Mosca A, Paleari R, Rubino FM, Zecca L, De Bellis G, Debernardi S, et al. Hb Abruzzo [β143(H21)His→Arg] identified by mass spectrometry and DNA analysis. Hemoglobin 1993;17:261-8.
14. 14. Wimberley PD, Burnett RW, Covingon AK, Fogh-Andersen N, Maas AHJ, Muller-Plathe O, et al. Guidelines for routine measurement of blood hemoglobin oxygen affinity. J Int Fed Clin Chem 1991;3: 81-6.
15. 15. Clegg JB, Naughton MA, Weatherall JD. Abnormal human haemoglobins, separation and characterization of the α and β chains by chromatography, and the determination of two new variants, Hb Chesapeake and Hb J (Bangkok). J Mol Biol 1966;19:91-108.
16. 16. Wilson JB, Lam H, Pravatmuang P, Huisman THJ. Separation of tryptic peptides of normal and abnormal α, β, and δ hemoglobin chains by high-performance liquid chromatography. J Chromatogr 1979;179:271-90.
17. 17. Fibach E, Manor D, Oppenheim A, Rachmilewitz EA. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989;73:100-3.
18. 18. Leone L, Monteleone M, Gabutti V, Amione C. Reversed-phase high-performance liquid chromatography of human haemoglobin chains. J Chromatogr 1985;321:407-19.
19. 19. Wajcman H, Vasseur C, Blouquit Y, Esperito Santo D, Peres MJ, Martins MC, et al. Hemoglobin Redondo [β92(F8)His→Asn]: an unstable hemoglobin variant associated with heme loss which occurs in two forms. Am J Hematol 1991;38:194-200.
20. 20. Wajcman H, Kister J, Vasseur C, Blouquit Y, Trastour JC, Cottenceau D, Galacteros F. Structure of the EF corner favors deamidation of asparaginyl residues in hemoglobin: the example of Hb La Roche-sur-Yon [β81(EF5)Leu→His]. Biochim Biophys Acta 1992;1138:127-32.
21. 21. Blackwell RQ, Hock Boon W, Liu CS, Weng MI. Hemoglobin J Singapore: α78Asn→Asp; α79Ala→Gly. Biochim Biophys Acta 1972;278:482-90.
22. 22. Moo-Penn WF, Jue DL, Bechtel KC, Johnson MH, Schmidt RM, McCurdy PR, et al. Hemoglobin Providence. A human hemoglobin variant occurring in two forms in vivo. J Biol Chem 1976;251: 7557-62.
23. 23. Kattamis AC, Kelly KM, Ohene-Frempong K, Reilly MP, Keller M, Cubeddu R, et al. Hb Osler [β145(HC2)Tyr→Asp] results from posttranslational modification. Hemoglobin 1997;21:109-20.
24. 24. Seid-Akhavan M, Winter WP, Abramson RK, Rucknagel DL. Hemoglobin Wayne: a frameshift mutation detected in human hemoglobin alpha chains. Proc Natl Acad Sci U S A 1976;73:882-6.
25. 25. Galletti P, Ingrosso D, Manna C, Clemente G, Zappia V. Protein damage and methylation-mediated repair in the erythrocyte. Biochem J 1995;306:313-25.
26. 26. Wright HT. Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. Crit Rev Biochem Mol Biol 1991;26: 1-52.
27. 27. Wright HT. Sequence and structure determinants of the nonenzymatic deamidation of asparagine and glutamine residues in proteins. Protein Eng 1991;4:283-94.
28. 28. Robinson AB. Evolution and the distribution of glutamyl and asparaginyl residues in proteins. Proc Natl Acad Sci U S A 1974;71:885-8.
29. 29. Clarke S. Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. Int J Peptide Protein Res 1987;808-21.
30. 30. Ingrosso D, Clarke S. Human erythrocyte D-aspartyl/L-isoaspartyl methyltransferases: enzymes that recognize age-damaged proteins. Adv Exp Med Biol 1991;307:263-75.
31. 31. Momand JA, Clarke S. The fidelity of protein synthesis: can mischarging by aspartyl-tRNA (Asp) synthetase lead to the formation of isoaspartyl residues in proteins? Biochim Biophys Acta 1990;1040:153-8.
32. 32. Clarke ND. A proposed mechanism for the self-splicing of proteins. Proc Natl Acad Sci U S A 1994;91:11084-8.
33. 33. Bischoff R, Kolbe HV. Deamidation of asparagine and glutamine residues in proteins and peptides: structural determinants and analytical methodology. J Chromatogr B 1994;662:261-78.
34. 34. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
35. 35. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A 1989;86:587-91.
36. 36. Yuasa I, Umetsu K, Vogt U, Nakamura H, Nanba E, Tamaki N, Irizawa Y. Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S. Hum Genet 1997;99:393-8.
37. 37. Rouger H, Valentin C, Craescu CT, Galacteros F, Cohen-Solal M. Five unknown mutations in the LR pyruvate kinase gene associated with severe hereditary nonspherocytic haemolytic anemia in France. Br J Haematol 1996;92:825-30.